Fredun Medhora, Managing Director, Fredun Prescribed drugs
Fredun Prescribed drugs has launched “Hormone Vary Merchandise,” a premium speciality therapeutics brand targeted on longevity, hormone well being, restoration science and human efficiency options.
The transfer marks Fredun’s strategic entry right into a quickly increasing, high-value healthcare segment pushed by growing international demand for preventive, performance-oriented, and precision-based therapeutics.
Constructed on a doctor-led, moral and evidence-backed pharmaceutical mannequin, the hormone vary merchandise mix scientific credibility with a digital-first affected person and physician engagement ecosystem to ship an built-in healthcare expertise targeted on outcomes, adherence, and long-term affected person worth.
Shift in the direction of preventive and performance-based healthcare
The vary is designed to handle the rising shift from conventional illness administration to wholesome lifespan optimisation, preventive care, and superior efficiency therapeutics, the corporate mentioned.
The preliminary portfolio consists of therapies and formulations based mostly on testosterone and its salts, nandrolone, development hormone-oriented options and supportive hormone optimisation therapies, developed to fulfill specialised scientific necessities below acceptable medical supervision. The platform is additional supported by protocol-driven affected person monitoring, physician engagement, and direct-to-patient fulfilment capabilities designed to enhance therapy continuity and affected person adherence.
Leveraging pharma experience for premium therapeutics development
The brand leverages Fredun Prescribed drugs’ established strengths in pharmaceutical formulation improvement, quality-focused manufacturing and international distribution capabilities, whereas creating new alternatives in premium, innovation-driven therapeutic segments.
With growing client and medical concentrate on vitality, metabolic well being, restoration science, and preventive wellness, Fredun believes its hormone vary merchandise are well-positioned to handle an evolving market alternative by a trusted, outcomes-focused, and ethically pushed pharmaceutical method.
Administration imaginative and prescient for high-science healthcare enlargement
Fredun Medhora, Managing Director, Fredun Prescribed drugs, mentioned as the corporate strikes up the worth chain, the main target will likely be on getting into segments that demand excessive scientific rigour, scientific validation and manufacturing excellence.
The product vary displays the corporate’s imaginative and prescient to convey medical experience and evidence-based formulations collectively for creating a reputable presence in hormone and efficiency therapeutics, he added.
Printed on Might 16, 2026
Source link
#Fredun #enters #highvalue #hormone #therapeutics #segment #speciality #brand #launch
